CVSGF Stock Chart & Stats
$15.88
-$0.25(-1.55%)
―
--
Day’s Range― - ―
52-Week Range$14.00 - $20.39
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
$1.10B
Enterprise Value$1.10B
Total Cash (Recent Filing)$12.30M
Total Debt (Recent Filing)$272.50M
Price to Earnings (P/E)54.4
Beta0.80
Next Earnings
Sep 24, 2026EPS Estimate
0.62Next Dividend Ex-DateN/A
Dividend Yield0.68%
Share Statistics
EPS (TTM)0.22
Shares Outstanding68,747,690
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.99
Price to Sales (P/S)1.33
P/FCF Ratio16.10
Enterprise Value/Market Cap1.00
Enterprise Value/Revenue1.59
Enterprise Value/Gross Profit4.08
Enterprise Value/Ebitda8.90
Forecast
1Y Price Target
$20.82Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.01
Revenue Forecast (FY)$9.96M
Bulls Say, Bears Say
Bulls Say
Integrated Business Model & ScaleCVS Group’s vertically integrated network—clinics, diagnostics, crematoria and training—creates durable cross-referral revenue streams and operational synergies. Scale across services supports steady demand capture, higher client retention and diversified cashflows versus single-service peers.
Strong Free Cash Flow GrowthA 90.1% increase in free cash flow signals material improvement in cash generation and conversion. This strengthens the firm’s ability to fund organic reinvestment, remediate leverage, pursue targeted M&A or sustain working capital, improving structural financial flexibility over months.
Improved Leverage ProfileDebt-to-equity improving to 0.83 indicates meaningful deleveraging and better capital structure management. Lower leverage reduces interest and refinancing risk, providing resilience to cyclical pressures and greater capacity for strategic investment or bolt-on acquisitions over the medium term.
Bears Say
Gross Margin CompressionA near 4.4 percentage-point drop in gross margin points to structural cost inflation or weakening pricing power in core services and product sales. Sustained margin pressure compresses operating leverage, reducing capacity to fund growth or absorb cost shocks without pricing changes.
Low Net Profit MarginA net margin below 3% limits retained earnings and the firm's ability to fund capex, dividends or aggressive expansion internally. Persistently thin profitability increases sensitivity to small revenue or cost swings, constraining long-term return generation for shareholders.
Weak Return On Equity / Moderate Equity RatioLow ROE and only a moderate equity ratio suggest the business struggles to convert capital into returns. Over time this can limit investor appeal and capital access, forcing reliance on debt or slower organic growth to improve capital efficiency and shareholder outcomes.
CVS Group plc News
CVSGF FAQ
What was CVS Group PLC’s price range in the past 12 months?
CVS Group PLC lowest stock price was $14.00 and its highest was $20.39 in the past 12 months.
What is CVS Group PLC’s market cap?
CVS Group PLC’s market cap is $1.10B.
When is CVS Group PLC’s upcoming earnings report date?
CVS Group PLC’s upcoming earnings report date is Sep 24, 2026 which is in 60 days.
How were CVS Group PLC’s earnings last quarter?
CVS Group PLC released its earnings results on Feb 26, 2026. The company reported $0.536 earnings per share for the quarter, missing the consensus estimate of $0.579 by -$0.043.
Is CVS Group PLC overvalued?
According to Wall Street analysts CVS Group PLC’s price is currently Undervalued.
Does CVS Group PLC pay dividends?
CVS Group PLC pays a Notavailable dividend of $0.112 which represents an annual dividend yield of 0.68%. See more information on CVS Group PLC dividends here
What is CVS Group PLC’s EPS estimate?
CVS Group PLC’s EPS estimate is 0.62.
How many shares outstanding does CVS Group PLC have?
CVS Group PLC has 68,747,690 shares outstanding.
What happened to CVS Group PLC’s price movement after its last earnings report?
CVS Group PLC reported an EPS of $0.536 in its last earnings report, missing expectations of $0.579. Following the earnings report the stock price went down -4.964%.
Which hedge fund is a major shareholder of CVS Group PLC?
Currently, no hedge funds are holding shares in CVSGF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Group plc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$20.82 (― Downside)
$20.82 (― Downside)
Insider Transactions
Bought Shares
Worth $16.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
49.94%
12-Months-Change
Fundamentals
Return on Equity
0.68%
Trailing 12-Months
Asset Growth
2.97%
Trailing 12-Months
Company Description
CVS Group PLC
CVS Group plc, established in 1999 and based in Diss, United Kingdom, is a comprehensive animal care provider with diverse operations. The company's activities are broadly categorized into four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It manages a large network of animal veterinary clinics and complementary diagnostic laboratories. CVS Group also offers pet cremation services, including the disposal of clinical waste for veterinary practices, and provides pet burial grounds. Furthermore, the company operates Animed Direct, an e-commerce platform that functions as an online pharmacy and retail outlet, distributing both prescription and over-the-counter animal medications, premium pet nutrition, and various other pet care essentials. Additional services include the supply of veterinary instrumentation and referral services. Currently, CVS Group's portfolio comprises 506 veterinary practices, 3 laboratories, 7 crematoria, and a dedicated online pharmacy.
CVSGF Stock 12 Month Forecast
Average Price Target
$20.82
Ownership Overview
0.08% Insiders
13.38% Mutual Funds
― Other Institutional Investors
81.25% Public Companies and
Individual Investors